Market Place
Sourcing Support
Excipient Market Overview: Roquette, Seqens, Evonik make strategic moves; new guidelines deal with contamination
The pharmaceutical industry has long recognized the critical role
excipients or inactive ingredient
FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments
This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s
FDA’s Drug Approvals in 2015: Novel Drugs & New Versions of Existing Drugs
Each year,
the US Food and Drug Administration (FDA) approve hundreds
of new medications. A small su
Move over Statins, Sartans, Tinibs; it’s time for “Cholic chemistry”
Recently, FDA approved therapies to reduce double chin
(yes it’s possible!) and treat patients
